The progress and advances of biliary tract carcinoma chemotherapy

Q4 Medicine

中华肝胆外科杂志 Pub Date : 2019-11-28 DOI:10.3760/CMA.J.ISSN.1007-8118.2019.11.022

Xiaofan Li

引用次数: 0

Abstract

Compared with other tumors of digestive system such as colorectal cancer, the overall survival for advanced biliary tract carcinoma has not been prolonged greatly although some progress has been made on the optimization of the treatment. One of the reasons is that there is no effective chemotherapy for biliary tract cancer yet. In this review, we summarized the recent research findings on chemotherapy for BTC , thereby providing guidance on clinical practice. Key words: Biliary tract neoplasms; Antineoplastic combined chemotherapy protocols; Review

查看原文本刊更多论文

胆道癌化疗的进展与进展

与结肠直肠癌等其他消化系统肿瘤相比，晚期胆道癌的总生存期并没有明显延长，但在优化治疗方面取得了一些进展。其中一个原因是目前还没有针对胆道癌的有效化疗方法。本文就近年来BTC的化疗研究成果进行综述，以期对临床治疗提供指导。关键词:胆道肿瘤;抗肿瘤联合化疗方案;审查

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中华肝胆外科杂志 Medicine-Gastroenterology

CiteScore

0.20

自引率

0.00%

发文量

7101

期刊介绍： Chinese Journal of Hepatobiliary Surgery is an academic journal organized by the Chinese Medical Association and supervised by the China Association for Science and Technology, founded in 1995. The journal has the following columns: review, hot spotlight, academic thinking, thesis, experimental research, short thesis, case report, synthesis, etc. The journal has been recognized by Beida Journal (Chinese Journal of Humanities and Social Sciences). Chinese Journal of Hepatobiliary Surgery has been included in famous databases such as Peking University Journal (Chinese Journal of Humanities and Social Sciences), CSCD Source Journals of China Science Citation Database (with Extended Version) and so on, and it is one of the national key academic journals under the supervision of China Association for Science and Technology.